Root extract taken for tiredness, mental strain, and physical output. The clearest signal is in people already depleted or under pressure: less exhaustion, better concentration, and effort that feels easier before exercise. Mood effects are smaller and inconsistent. Longevity evidence comes only from flies, worms, and yeast. Product substitution and industry-funded research keep confidence low. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Morning salivary cortisol | 0.30–0.80 µg/dL within 30 min of waking | The one hormonal pathway with measured human effect |
| Cortisol awakening response | 50–75% rise from waking to +30 min | Detects the blunting reported in fatigued users |
| Alanine aminotransferase | 10–26 U/L (men), 10–19 U/L (women) | Screens for liver strain from the extract or from an adulterant |
| Fasting glucose | 75–86 mg/dL | Caution is advised alongside glucose-lowering therapy |
| Resting heart rate | 50–65 beats per minute | Captures both the mild slowing seen in trials and any overstimulation |
| Blood pressure | 105–120 / 65–80 mmHg | Additive lowering with antihypertensives and other adaptogens |
| High-sensitivity C-reactive protein | Below 0.5 mg/L | Tests the claimed anti-inflammatory effect directly |
| Trough level of any narrow-therapeutic-index drug | No rhodiola-specific target; track change from the individual's own pre-rhodiola trough, inside that drug's therapeutic window | The only interaction with a plausible clinical consequence |
Cadence: Subjective measures at 2 and 4 weeks; blood pressure and resting heart rate at 4 weeks; liver enzyme, glucose, and any interacting drug level at 12 weeks, then every 6–12 months if use continues.